The hematological and neurological expressed 1 (HN1) gene is upregulated in various types of cancer, and growing evidence suggests that HN1 contributes to tumor progression in several malignancies (Javed et al., 2023; Liu et al., 2020). The gene discussed is JPT1; the disease is cancer.